Sorivudine
Cat. No.：YN290184
CAS No. ：77181-69-2
| 产品名称: | Sorivudine |
| CAS No.: | 77181-69-2 |
| Chemical Name: | (E)-1-β-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione; 1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione; (E)-5-(2-Bromovinyl)-1-(β-D-arabinofuranosyl)uracil; 1-β-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil; 1- |
| Synonyms: | BV-araU |
| 分子量: | 349.13 |
| 分子式: | C₁₁H₁₃BrN₂O₆ |
| SMILES: | O=C1NC(C(/C=C/Br)=CN1[C@H]2[C@H]([C@@H]([C@@H](CO)O2)O)O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Sorivudine (BV-araU) 是一种口服活性的，合成的嘧啶核苷抗代谢 (pyrimidine nucleoside antimetabolite) 药物。Sorivudine 的抗病毒活性来自某些 DNA 病毒中存在的特定胸苷激酶 (thymidine kinase) 选择性转化为核苷酸，从而反过来会干扰病毒 DNA 合成 (DNA synthesis)。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Burke, M., et al.: Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates), 16, 1231 (2016)
Malinovskaya, V. V., et al.: Russ., RU 2411039 C2 20071226 (2011)
Ryoo, J.P., et al.: PCT Int. Appl., WO 2014159731 A1 20141002 (2014)
